Therefore, the identification of novel antidepressant effect targets, especially those that regulate both BDNF-dependent rapid antidepressant action and serotonergic neurotransmission-mediated long-lasting antidepressant effect, is extremely significant for depression prevention and treatment. This evidence concerns the gene BDNF and depressive disorder.